|
|
 |
专题栏目 |
 |
|
相关文章 |
|
|
|
|
|
 |
Topoisomerase II inhibitors for proliferative vitreoretinopathy |
热 |
|
| Topoisomerase II inhibitors for proliferative vitreoretinopathy |
|
作者：HSI-KUNG… 文章来源：1Department of Ophthalmology, Chang-Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan 2Tissue Culture Center, New York Eye and Ear Infirmary, New York Medical College, New York, USA 点击数：9348 更新时间：2006/7/11 23:11:06 
|
|
| Purpose: The aim of this study was to compare the effect of some commercially available topoisomerase II inhibitors on the proliferation of retinal pigment epithelium (RPE) cells in vitro and test the toxicity and efficacy against experimental proliferative vitreoretinopathy (PVR).
Methods: Study medications included etoposide, doxorubicin, and daunorubicin. Rabbit RPE cells were seeded without (control) or with the drugs at various medicine concentrations (100, 30, 10, 1.0, 0.1, 0.01ug/ml). MTT assay was used to determine cell survival and proliferation rate at 48hours and 96hours. Four rabbits were used to study toxicity of etoposide To evaluate retinal toxicity, bilateral simultaneous electroretinograms (ERGs) were obtained. Five rabbits were used to further study the efficacy of etoposide against experimental PVR.
Results: The slope of dose-response curve was slowly declined for etoposide, but very sharp for doxorubicin and daunorubicin in MTT assay. Etoposide was selected for further toxicity and efficacy tests. There was no significant change in b-wave amplitudes in etoposide (0.02 mg, 10μg/ml)-injected eyes after 2 weeks, but significant reduction in etoposide (0.2 mg, 100μg/ml)-injected eyes. Ten days after gas compression vitrectomy with 0.4 ml SF6, the right eyes of rabbits were injected with 1×105 cells of RPE and etoposide (0.02 mg/ 0.1 cc PBS) and the left eyes were injected with 1×105 cells of RPE and PBS 0.1cc. In the first 2 weeks, etoposide-injected eyes had statistically significant lower grading of PVR than the control eyes.
Conclusions: These results demonstrated etoposide would be an adjunctive for the prevention of PVR. Further pharmacokinetic study of intravitreal injection of etoposide is necessary for repeated intravitreal administrations.
|
|
|
| 会议投稿录入：毛进 责任编辑：毛进 |
|
|
上一篇会议投稿： Surgical management for proliferative diabetic retinopathy with diffuse retinal edema and massive subretinal hard exudates
下一篇会议投稿： 糖尿病大鼠视网膜中结缔组织生长因子的表达和他汀类/环氧合酶-2抑制剂对其的干预作用 |
|
|
| 【字体：小 大】【发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口】 |
|
 网友评论：（只显示最新10条。评论内容只代表网友观点，与本站立场无关！） |
| 没有任何评论 |
|
|
|
|
